NRIX insider files Form 144 to sell 11,008 shares

NRIX report: Christine Ring filed a Form 144 to sell 11,008 shares via exercise of stock options and related cash proceeds.

Rhea-AI Filing Summary

NRIX report: Christine Ring filed a Form 144 to sell 11,008 shares via exercise of stock options and related cash proceeds. The filing also lists prior 10b5-1 sales on ranging from 4/30/2026 to 6/25/2026 totaling multiple transactions with disclosed share counts and gross proceeds.

Insights

Corporate Governance Analyst

Routine insider dispositions under Rule 144 and a 10b5-1 plan are reported.

The filing lists a proposed sale of 11,008 shares tied to an exercise of stock options and multiple executed 10b5-1 sales between 4/30/2026 and 6/25/2026. These entries record amounts realized per transaction and follow standard Form 144 disclosure conventions.

Cash treatment for the option exercise is stated as Cash. Subsequent filings may show settlement details and actual transfers; timing and net proceeds after fees are not provided in this excerpt.

Key Figures

Proposed shares to be sold: 11,008 shares 10b5-1 sale (6/25/2026): 28,935 shares 10b5-1 sale (6/02/2026): 8,148 shares +4 more

7 metrics

Proposed shares to be sold 11,008 shares Exercise of stock options (07/02/2026)

10b5-1 sale (6/25/2026) 28,935 shares Sale dated 06/25/2026, gross proceeds $580,506.12

10b5-1 sale (6/02/2026) 8,148 shares Sale dated 06/02/2026, gross proceeds $135,252.73

10b5-1 sale (5/04/2026) 3,368 shares Sale dated 05/04/2026, gross proceeds $57,118.25

10b5-1 sale (5/04/2026) 4,780 shares Sale dated 05/04/2026, gross proceeds $81,091.74

10b5-1 sale (5/01/2026) 5,394 shares Sale dated 05/01/2026, gross proceeds $90,406.68

Transaction (4/30/2026) 3,214 shares Sale dated 04/30/2026, gross proceeds $53,497.99

Key Terms

10b5-1, Exercise of Stock Options, Rule 144

3 terms

10b5-1 regulatory

"10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Securities To Be Sold | 07/02/2026 | Exercise of Stock Options"

Rule 144 regulatory

"Form 144 reporting of proposed sale under Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Christine Ring's Form 144 mean for NRIX shareholders?

It reports a proposed sale of 11,008 shares by Christine Ring via option exercise. The filing documents the planned disposition and past 10b5-1 sales with dates and gross proceeds; it does not state market impact or net proceeds after fees.

Which past transactions does the Form 144 list for Christine Ring?

The filing lists multiple 10b5-1 sales on 4/30/2026, 5/01/2026, 5/04/2026, 6/02/2026, and 6/25/2026 with share counts and gross amounts disclosed for each transaction.

How many shares is Christine Ring proposing to sell on this Form 144?

The Form 144 shows a proposed sale of 11,008 shares described as resulting from an exercise of stock options, with the cash method of settlement indicated in the filing excerpt.

Was the cash treatment or method of sale specified in the filing?

Yes. The filing indicates the option exercise settlement method as Cash. The excerpt does not specify broker, exact settlement date, or net proceeds after commissions and taxes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 04:28 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001817199
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NURIX THERAPEUTICS, INC.
SEC File Number	001-39398
Address of Issuer	1600 Sierra Point Parkway Brisbane CALIFORNIA 94005
Phone	4156605320
Name of Person for Whose Account the Securities are To Be Sold	CHRISTINE RING
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	11008	263201.28	103405813	07/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/02/2026	Exercise of Stock Options	Issuer			11008	07/02/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	06/25/2026	28935	580506.12
10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	06/02/2026	8148	135252.73
10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	05/04/2026	3368	57118.25
10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	05/04/2026	4780	81091.74
10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	05/01/2026	5394	90406.68
CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	04/30/2026	3214	53497.99

144: Remarks and Signature

Remarks
Date of Notice	07/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Christine Ring
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)